Physician profile
Jason Deluca
NPI 1568677300
$5,202.02
in general payments reported to CMS, 2019-2025
40 companies · $959 in 2025
The $959 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $419 · 2021: $681 · 2022: $629 · 2023: $671 · 2024: $897 · 2025: $959.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,527.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $1,157.94 | 2019-2025 | Xtampza, Belbuca |
| Medtronic, INC. | $620.11 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Nevro Corp. | $617.00 | 2019-2024 | Senza |
| Abbott Laboratories | $366.63 | 2019-2025 | Proclaim |
| Abbvie INC. | $247.65 | 2021-2025 | Botox |
| Protega Pharmaceutials INC | $236.75 | 2024-2025 | Roxybond |
| Allergan, INC. | $219.13 | 2019-2022 | |
| Si-Bone, INC. | $176.66 | 2019-2020 | |
| Boston Scientific Corporation | $163.22 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $157.35 | 2023-2025 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $135.40 | 2019-2023 | Relistor |
| Tersera Therapeutics LLC | $120.99 | 2025 | Prialt |
| Curonix LLC | $119.03 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Biodelivery Sciences International, INC. | $98.78 | 2019-2021 | |
| Saluda Medical Americas, INC. | $75.00 | 2024-2025 | Evoke |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Deluca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.